phase readout
saveNCT07479979: Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
RECRUITINGupdated 7h ago
community read0 votes
Sponsor: Natalie Callander. Phase: PHASE1. Conditions: Relapse Multiple Myeloma, Refractory Multiple Myeloma
view source ↗
comments(0)
5-min edit window · permanent after that